Clinical Trials List
2024-09-01 - 2030-10-28
Phase II
Recruiting4
ICD-10M34.0
Progressive systemic sclerosis
ICD-10M34.1
CR(E)ST syndrome
ICD-10M34.2
Systemic sclerosis induced by drug and chemical
ICD-10M34.89
Other systemic sclerosis
ICD-10M34.9
Systemic sclerosis, unspecified
ICD-9710.1
Systemic sclerosis
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張哲慈 Division of Rheumatology
- 陳彥輔 Division of Rheumatology
- Ping-Han Tsai Division of Rheumatology
- 吳振德 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張詩欣 風濕免疫科
- Chen Der-Yuan 風濕免疫科
- 黃建中 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
200 participants
